Seyedkazemi Setareh

CHIEF DEVELOPMENT OFFICER at Avalanche Biotechnologies, Inc.

Sold, on record
$18k
Dollars the filings state
Form 4 sales
3
Latest May 15, 2025
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
1
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale Avalanche Biotechnologies, Inc.Plan not stated
    Sep 19, 2022 2022

    Sold 6,058 shares at $1.07 ($6k)

    Seyedkazemi Setareh, Chief Development Officer

    Sold 11.2% of holdings ($58k position)47,875 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Avalanche Biotechnologies, Inc.No plan
    Sep 15, 2023 +361 days

    Sold 6,201 shares at $1.52 ($9k)

    Seyedkazemi Setareh, Chief Development Officer

    No 10b5-1 planSold 11.5% of holdings ($82k position)47,674 shares leftFiling

  3. 3 Form 4 sale Avalanche Biotechnologies, Inc.No plan
    May 15, 2025 +608 days

    Sold 924 shares at $2.00 ($2k)

    Seyedkazemi Setareh, CHIEF DEVELOPMENT OFFICER

    No 10b5-1 planSold 6.3% of holdings ($29k position)13,768 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Seyedkazemi Setareh
Source
May 15, 2025May 16, 2025Avalanche Biotechnologies, Inc.CHIEF DEVELOPMENT OFFICERForm 4 sale924$2k6.3%No planSEC
Sep 15, 2023Sep 18, 2023Avalanche Biotechnologies, Inc.Chief Development OfficerForm 4 sale6,201$9k11.5%No planSEC
Sep 19, 2022Sep 21, 2022Avalanche Biotechnologies, Inc.Chief Development OfficerForm 4 sale6,058$6k11.2%Plan not statedSEC